Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study.
about
Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Trastuzumab-based Retreatment ...... ety of Medical Oncology Study.
@en
type
label
Trastuzumab-based Retreatment ...... ety of Medical Oncology Study.
@en
prefLabel
Trastuzumab-based Retreatment ...... ety of Medical Oncology Study.
@en
P2093
P1476
Trastuzumab-based Retreatment ...... ety of Medical Oncology Study.
@en
P2093
Abdurrahman Isikdogan
Dogan Koca
Dogan Uncu
Erkan Arpaci
Ibrahim Turker
Ibrahim Vedat Bayoglu
Mehmet Artac
Mehmet Kucukoner
Mutlu Dogan
P304
P50
P577
2015-01-01T00:00:00Z